Clinical Trials
All Clinical Trials - Page 2 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07191873Phase 4Recruiting
Tirzepatide in Idiopathic Intracranial Hypertension Trial
Tirzepatide
- NCT07754461Phase 3Recruiting
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Survodutide
- NCT07776977N/ARecruiting
Bedtime Device Restriction and Desmopressin in PMNE.
Desmopressin
- NCT07693608Phase 2Enrolling By Invitation
An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder
Tirzepatide
- NCT07720466N/ANot Yet Recruiting
Salivary Function and Dental Changes During GLP-1 Therapy
Tirzepatide
- NCT07777575Phase 4Not Yet Recruiting
Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide
Tirzepatide
- NCT07771283N/AEnrolling By Invitation
Purpose to Evaluate the Effectiveness of the Superovulation Stimulation Protocol Using Human Chorionic Gonadotropin (hCG) by Demonstrating Its Equivalence to Standard Controlled Ovarian Stimulation Protocols in Terms of Oocytes Retrieved, Blastulation While Maintaining an Economic Advantage
Gonadorelin
- NCT06732245Phase 2Not Yet Recruiting
Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese
Tirzepatide
- NCT07728318N/ANot Yet Recruiting
Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients
Tirzepatide
- NCT07770841Phase 3Recruiting
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Semaglutide
- NCT07734792Phase 2/Phase 3Not Yet Recruiting
Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial
Tirzepatide
- NCT07563699Phase 1/Phase 2Recruiting
Safety, Tolerability and Efficacy of Semaglutide Depot in Subjects With Type-2 Diabetes Mellitus
Semaglutide
- NCT07760532N/ANot Yet Recruiting
Comparing Facial Aging Between Identical Twins With 3D Imaging
Tirzepatide
- NCT07554638Phase 4Recruiting
Incretin Therapies in Obesity-related HFpEF
Tirzepatide
- NCT07213323N/ARecruiting
Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment
Tirzepatide
- NCT07745504Phase 3Not Yet Recruiting
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Semaglutide
- NCT07282613Phase 3Not Yet Recruiting
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Semaglutide
- NCT07751133Phase 3Not Yet Recruiting
Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer
Gonadorelin
- NCT07757087Phase 1Recruiting
A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Obesity, Compared to a Low-calorie Diet or Placebo
Amycretin
- NCT07630454Phase 4Not Yet Recruiting
Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF
Tirzepatide
- NCT07619989N/ARecruiting
Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor Agonists
Tirzepatide
- NCT07671248Phase 3Not Yet Recruiting
Tirzepatide in the Treatment of Cannabis Use Disorder
Tirzepatide
- NCT07676331Phase 2Not Yet Recruiting
Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial
Tirzepatide
- NCT07592546Phase 4Not Yet Recruiting
Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss
Semaglutide
- NCT07668765N/ANot Yet Recruiting
GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity
Tirzepatide
- NCT07078838Phase 2Not Yet Recruiting
Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
Tirzepatide
- NCT07671391Phase 2Not Yet Recruiting
A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body in Obese Participants
Tirzepatide
- NCT07298915Phase 3Not Yet Recruiting
The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)
Tirzepatide
- NCT07653477Phase 3Not Yet Recruiting
Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)
Semaglutide
- NCT07455903Phase 2Recruiting
Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
Gonadorelin
- NCT07684144Phase 3Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Maridebart-Cafraglutide
- NCT07218354Phase 3Recruiting
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)
Semaglutide
- NCT07573163Phase 2Recruiting
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion
Tirzepatide
- NCT07588438Phase 4Recruiting
Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.
Tirzepatide
- NCT07684235Phase 3Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Maridebart-Cafraglutide
- NCT07496463Phase 2Enrolling By Invitation
Setmelanotide to Treat Obesity in a Patient With Pseudohypoparathyroidism Type 1a (PHP1a)
Setmelanotide
- NCT07697391Phase 4Not Yet Recruiting
AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes
Tirzepatide
- NCT07728669N/ARecruiting
Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy
Semaglutide
- NCT07679516N/ANot Yet Recruiting
Postprandial Regulation of Bone Perfusion in Healthy Individuals
Pramlintide
- NCT07738276Phase 3Not Yet Recruiting
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With Obesity
Tirzepatide
- NCT07613307Phase 3Recruiting
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
Orforglipron
- NCT07627191EARLY_Phase 1Not Yet Recruiting
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
Semaglutide
- NCT06820281Phase 2Recruiting
Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes
Tirzepatide
- NCT07662213Phase 3Recruiting
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Semaglutide
- NCT07531251Phase 4Recruiting
Clinical Trial in Patients With Barth Syndrome- 4TAZPower
Elamipretide
- NCT07622992N/ANot Yet Recruiting
Preoperative Optimization With Tirzepatide, Ketogenic Diet, or Standard Care Before One Anastomosis Gastric Bypass Surgery
Tirzepatide
- NCT07265752Phase 2Not Yet Recruiting
Tirzepatide for the Treatment of Cannabis Use Disorder
Tirzepatide
- NCT07635953Phase 3Not Yet Recruiting
New Triple Combination Therapy in Newly Diagnosed Type 2 Diabetes
Tirzepatide
- NCT07636239N/ANot Yet Recruiting
Eating Behavior, Nutritional Status and Appetite Hormones After Bariatric Surgery
Ghrp-6
- NCT07403604Phase 1Recruiting
Effect of Insulin Lowering on Lipogenesis
Octreotide